Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen).

Abstract

A subset of peripheral blood T lymphocytes coexpressing CD3 and IgG Fc receptors (FcR) (CD16/Leu-11 antigen) have been identified, isolated, and functionally characterized. The CD3+, CD16+ cells were established in short-term culture using growth medium containing interleukin 2 (IL-2). Both the freshly isolated cells and the cultured cell line stably expressed the CD3+, CD16+ phenotype. Furthermore, a majority of these T cells lacked either CD4 or CD8 expression. Like in vitro-activated cytotoxic T lymphocytes and natural killer (NK) cells, the CD3+, CD16+ cells showed numerous azurophilic granules. Although these cells failed to mediate significant levels of NK cell-mediated cytotoxicity even after stimulation with IL-2, they efficiently functioned as effectors of antibody-dependent cellular cytotoxicity (ADCC). The Ig isotype specificity of the ADCC was analyzed using an isotype switch-variant family of a murine anti-HLA monoclonal antibody (mAb). Similar to the CD3-, CD16+ NK cell population, the CD3+, CD16+ T cells preferentially used the IgG2a antibody to mediate ADCC. The CD3+, CD16+ cells demonstrated a proliferative response when cocultured with either a NK-sensitive tumor cell line, K562, or a NK-insensitive B lymphoblastoid cell line, CCRF-SB. The response against CCRF-SB was significantly inhibited by anti-IL-2 receptor antibody, whereas the response against K562 was only partially diminished. Cytotoxicity was also induced in the CD3+, CD16+ population by the presence of anti-CD3 mAb, indicating that cytotoxicity can be triggered by stimulation via the CD3-T cell antigen receptor complex. By isolating these CD3+, CD16+ cells from the peripheral blood of a normal, healthy individual, it has been possible to extensively study the morphology, antigenic phenotype, and functional behavior of this unique subset of T lymphocytes expressing IgG FcR.

Vγ9Vδ2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs—Rituximab and trastuzumab

“…16 CD3 1 CD16 1 T cells (a population that contains a large proportion of Vg9Vd2 T cells) or CD16 1 gd T cells can efficiently mediate antibody dependent cellular cytotoxicity (ADCC) via CD16. 17,18 Although CD16 is a low affinity receptor for IgG Fc, IgG-coated cells can bind and activate CD16 positive gd T cells through CD16. 13,18 Therefore, via ADCC, Vg9Vd2 T cells could potentially enhance the antitumor activity of therapeutic monoclonal antibodies that have human Fc portions.…”

Induced Expression of FcγRIIIa (CD16a) on CD4+ T Cells Triggers Generation of IFN-γhigh Subset

“…Fc␥RIIIa expression was observed in a small number of peripheral T-cells in healthy individuals in earlier studies (13,14). Another study showed that IgM binding T-cells provided helper function, while IgG binding cells provided suppressor function (15).…”

Clonal proliferation of large granular lymphocytes in rheumatoid arthritis

“…Mixing experiments using leukemic T cell DNA and normal DNA have shown that the presence of 1% leukemic cell DNA can easily be detected using TP gene rearrangement studies (ref. 17 and Kidd P: unpublished observations). Thus, the sensitivity of this method, together with the finding that few, if any, mononuclear cells studied from patients with FS had the abnormal CD3+, CD16+ phenotype observed in those from patients with LGL leukemia, makes it unlikely that these patients have a minor clonal population of circulating LGLs.…”